gossypol has been researched along with zoledronic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atmaca, H; Cengiz, E; Erten, C; Gorumlu, G; Gul, MK; Karabulut, B; Karaca, B; Kucukzeybek, Y; Sanli, UA; Uslu, R; Uzunoglu, S | 1 |
| Atmaca, H; Cirak, Y; Degirmenci, M; Gorumlu, G; Karabulut, B; Karaca, B; Purcu, DU; Sanli, UA; Tunali, D; Uslu, R; Uzunoglu, S | 1 |
2 other study(ies) available for gossypol and zoledronic acid
| Article | Year |
|---|---|
Targeting apoptosis in the hormone- and drug-resistant prostate cancer cell line, DU-145, by gossypol/zoledronic acid combination.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Bone Density Conservation Agents; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Male; Diphosphonates; DNA Fragmentation; Drug Resistance, Neoplasm; Drug Synergism; Gossypol; Hormones; Humans; Imidazoles; Male; Prostatic Neoplasms; Zoledronic Acid | 2009 |
Combined gossypol and zoledronic acid treatment results in synergistic induction of cell death and regulates angiogenic molecules in ovarian cancer cells.
Topics: Angiogenesis Inducing Agents; Caspase 3; Caspase 7; Cell Death; Cell Line, Tumor; Cell Proliferation; Diphosphonates; DNA Fragmentation; Down-Regulation; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Gossypol; Humans; Imidazoles; Ovarian Neoplasms; RNA, Messenger; Zoledronic Acid | 2009 |